Serum Concentrations of Insulin-like Growth Factor (IGF)-1 and IGF Binding Protein-3 (IGFBP-3), IGF-1/IGFBP-3 Ratio, and Markers of Bone Turnover: Reference Values for French Children and Adolescents and z-Score Comparability with Other References

被引：63
作者：
Alberti, Corinne [2 ,3 ,4 ]
Chevenne, Didier [5 ]
Mercat, Isabelle [6 ]
Josserand, Emilie [2 ]
Armoogum-Boizeau, Priscilla [2 ]
Tichet, Jean [6 ]
Leger, Juliane [1 ,4 ,7 ,8 ]
机构：
[1] Hop Robert Debre, AP HP, Pediat Endocrinol Dept,INSERM, Ctr Reference Malad Endocriniennes Croissance,U67, F-75019 Paris, France
[2] Hop Robert Debre, AP HP, Unite Epidemiol Clin, F-75019 Paris, France
[3] INSERM, CIC EC CIE5, Paris, France
[4] Univ Paris Diderot, Paris, France
[5] Hop Robert Debre, AP HP, Serv Biochim Hormonol, F-75019 Paris, France
[6] Reg Inst Hlth, Tours, France
[7] Hop Robert Debre, AP HP, Serv Endocrinol Pediat, F-75019 Paris, France
[8] INSERM, UMR 676, Paris, France
来源：
CLINICAL CHEMISTRY | 2011年 / 57卷 / 10期
关键词：
BODY-MASS INDEX; FACTOR-I; HEALTHY-CHILDREN; REFERENCE INTERVALS; BIOCHEMICAL MARKERS; REFERENCE RANGES; CHILDHOOD; PUBERTY; AGE; HORMONE;
D O I：
10.1373/clinchem.2011.169466
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
BACKGROUND: A reference model for converting serum growth factor and bone metabolism markers into an SD score (SDS) is required for clinical practice. We aimed to establish reference values of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein 3 (IGFBP-3) concentrations and bone metabolism markers in French children, to generate a model for converting values into SDS for age, sex, and pubertal stage. METHODS: We carried out a cross-sectional study of 1119 healthy white children ages 6-20 years. We assessed concentrations of serum IGF-1, IGFBP-3, carboxyterminal telopeptide alpha 1 chain of type I collagen (CrossLaps), and bone alkaline phosphatase concentrations and height, weight, and pubertal stage, and used semiparametric regression to develop a model. RESULTS: A single regression model to calculate the SDSs with an online calculator was provided. Apositive relationship was found between SDS for serum IGF-1 and IGFBP-3, IGF/IGFBP-3 mol/L ratio, and anthropometric parameters (P < 0.0001), with slightly greater effects observed for height than for body mass index (BMI). There was a negative relationship between serum CrossLaps concentration and BMI, and a positive relationship between serum CrossLaps concentration and height. A comparison of serum IGF-1 reference databases for children showed marked variation as a function of age and pubertal group; smooth changes with age and puberty were observed only in our model. CONCLUSIONS: This new model for the assessment of SDS reference values specific for age, sex, and pubertal stage may help to increase the diagnostic power of these parameters for the assessment of growth and bone metabolism disorders. This study also provides information about the physiological role of height and BMI for the interpretation of these parameters. (C) 2011 American Association for Clinical Chemistry
引用
收藏
页码：1424 / 1435
页数：12
相关论文
共 41 条
[1]   An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood [J].
Ben-Shlomo, Y ;
Holly, J ;
McCarthy, A ;
Savage, P ;
Davies, D ;
Gunnell, D ;
Smith, GD .
CLINICAL ENDOCRINOLOGY, 2003, 59 (03) :366-373
[2]   Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: Establishment of reference ranges with emphasis on puberty [J].
Bereket, A ;
Turan, S ;
Omar, A ;
Berber, M .
HORMONE RESEARCH, 2006, 65 (02) :96-105
[3]   Monitoring osteoporosis therapy: Bone mineral density, bone turnover markers, or both? [J].
Bonnick, SL ;
Shulman, L .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (04) :25S-31S
[4]   Construction of the World Health Organization child growth standards: selection of methods for attained growth curves [J].
Borghi, E ;
de Onis, M ;
Garza, C ;
Van den Broeek, J ;
Frongillo, EA ;
Grummer-Strawn, L ;
Van Buuren, S ;
Pan, H ;
Molinari, L ;
Martorell, R ;
Onyango, AW ;
Martines, JC .
STATISTICS IN MEDICINE, 2006, 25 (02) :247-265
[5]   Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system:: Results from a multicenter study [J].
Brabant, G ;
von zur Mühlen, A ;
Wüster, C ;
Ranke, MB ;
Kratzsch, J ;
Kiess, W ;
Ketelslegers, JM ;
Wilhelmsen, L ;
Hulthén, L ;
Saller, B ;
Mattsson, A ;
Wilde, J ;
Schemer, R ;
Kann, P .
HORMONE RESEARCH, 2003, 60 (02) :53-60
[6]   Associations of childhood and adulthood height and the components of height with insulin-like growth factor levels in adulthood: A 65-year follow-up of the Boyd Orr cohort [J].
Bray, I ;
Gunnell, D ;
Holly, JMP ;
Middleton, N ;
Smith, GD ;
Martin, RM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04) :1382-1389
[7]   Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: Comparison with five widely used IGF-I immunoassays [J].
Brugts, Michael P. ;
Ranke, Michael B. ;
Hofland, Leo J. ;
van der Wansem, Katy ;
Weber, Karin ;
Frystyk, Jan ;
Lamberts, Steven W. J. ;
Janssen, Joseph A. M. J. L. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (07) :2539-2545
[8]   Biochemical markers of bone formation in Thai children and adolescents [J].
Chailurkit, L ;
Suthutvoravut, U ;
Mahachoklertwattana, P ;
Charoenkiatkul, S ;
Rajatanavin, R .
ENDOCRINE RESEARCH, 2005, 31 (03) :159-169
[9]   Free rather than total circulating insulin-like growth factor-I determines the feedback on growth hormone release in normal subjects [J].
Chen, JW ;
Hojlund, K ;
Beck-Nielsen, H ;
Christiansen, JS ;
Orskov, H ;
Frystyk, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :366-371
[10]   Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays [J].
Clemmons, David R. .
CLINICAL CHEMISTRY, 2011, 57 (04) :555-559
12345